PMC:7402624 / 544-642 JSONTXT

{"project":"LitCovid-PD-FMA-UBERON","denotations":[{"id":"T4","span":{"begin":18,"end":29},"obj":"Body_part"},{"id":"T5","span":{"begin":71,"end":76},"obj":"Body_part"}],"attributes":[{"id":"A4","pred":"fma_id","subj":"T4","obj":"http://purl.org/sig/ont/fma/fma84371"},{"id":"A5","pred":"fma_id","subj":"T5","obj":"http://purl.org/sig/ont/fma/fma68646"}],"text":"ral infection and plasmablast responses reaching \u003e30% of circulating B cells. However, another sub"}

{"project":"LitCovid-PD-MONDO","denotations":[{"id":"T5","span":{"begin":4,"end":13},"obj":"Disease"}],"attributes":[{"id":"A5","pred":"mondo_id","subj":"T5","obj":"http://purl.obolibrary.org/obo/MONDO_0005550"}],"text":"ral infection and plasmablast responses reaching \u003e30% of circulating B cells. However, another sub"}

{"project":"LitCovid-PD-CLO","denotations":[{"id":"T11","span":{"begin":69,"end":76},"obj":"http://purl.obolibrary.org/obo/CL_0000236"}],"text":"ral infection and plasmablast responses reaching \u003e30% of circulating B cells. However, another sub"}